Anthony Rossomando
16Patents
4h-index
18Co-inventors
53Inventor score
Filing activity: Jan 31, 2003 → Sep 29, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7442370B2 | Polymer conjugates of mutated neublastin | Chemistry; Metallurgy | 18 | Expired |
| US7276580B2 | Neurotrophic factors | Human Necessities | 12 | Expired |
| US7655463B2 | Methods of activating RET receptor tyrosine kinase using neurotrophic factors | Human Necessities | 11 | Active |
| US7358228B2 | Methods of treating pain using neurotrophic factors | Human Necessities | 11 | Active |
| US8722862B2 | Refolding transforming growth factor beta family proteins | Emerging Cross-Sectional Technologies | 3 | Active |
| US8642732B2 | Polymer-conjugated glycosylated neublastin | Human Necessities | 2 | Active |
| US8217146B2 | Neurotrophic factors and methods of use thereof | Human Necessities | 2 | Active |
| US8329655B2 | Methods for increasing vascularization | Chemistry; Metallurgy | 2 | Active |
| US8163875B2 | Polymer conjugated glycosylated neublastin | Human Necessities | 2 | Active |
| US8119114B2 | Polymer conjugates of mutated neublastin | Chemistry; Metallurgy | 2 | Active |
| US8263553B2 | Neublastin variants | Emerging Cross-Sectional Technologies | 2 | Active |
| US10047150B2 | Anti-neublastin antibodies and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10328125B2 | Treatments for neurological disorders | Human Necessities | 0 | Active |
| US10413597B2 | Methods of treating Mucopolysaccharidosis IIIB (MPSIIIB) | Chemistry; Metallurgy | 0 | Active |
| US9138461B2 | Compositions and methods for increasing vascularization | Chemistry; Metallurgy | 0 | Active |
| US8969042B2 | Refolding transforming growth factor beta family proteins | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.